These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27322945)

  • 1. Diagnostic and Therapeutic Challenges.
    Corvi F; Lattanzio R; Miserocchi E; Querques L; Bandello F; Querques G; Croft DE; Wykoff CC
    Retina; 2016 Nov; 36(11):2239-2245. PubMed ID: 27322945
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic challenges.
    Querques G; Lattanzio R; Querques L; Bandello F; Freund KB
    Retina; 2013 Jan; 33(1):240-3. PubMed ID: 23095768
    [No Abstract]   [Full Text] [Related]  

  • 3. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
    Yang HS; Park SH
    Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic and therapeutic challenges.
    Mukkamala SK; Yannuzzi LA; Agarwal A
    Retina; 2012; 32(10):2171-4. PubMed ID: 23026848
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy.
    Lee GD; Chen VM; Barnes AC; Goldman DR; Duker JS
    J AAPOS; 2014 Jun; 18(3):303-5. PubMed ID: 24924285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply.
    Spaide RF
    Ophthalmology; 2016 Mar; 123(3):e24-5. PubMed ID: 26902575
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Spaide et al.: Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2 (Ophthalmology 2015;122:2261-9).
    Chen Z; Huang D; Izatt JA; Wang RK; Werner JS; Yasuno Y
    Ophthalmology; 2016 Mar; 123(3):e24. PubMed ID: 26902576
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinal angiomatous proliferation with chorioretinal anastomosis in childhood Coats disease: a reappraisal of macular fibrosis using multimodal imaging.
    Sigler EJ; Calzada JI
    Retina; 2015 Mar; 35(3):537-46. PubMed ID: 25170864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoschisis in the setting of Coats' disease.
    Yannuzzi NA; Tzu JH; Hess DJ; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):172-4. PubMed ID: 24635161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of repeated anti-vascular endothelial growth factor therapy in eyes with retinal pigment epithelial tears.
    Moreira CA; Arana LA; Zago RJ
    Retina; 2013 Feb; 33(2):277-81. PubMed ID: 23023526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
    Battaglia Parodi M; Iacono P; Bandello F
    Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Mommy... I Can't See With My Eye". Coats disease with foveal exudation (Stage 2b).
    Yeung HH
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):76-7, 89. PubMed ID: 27018878
    [No Abstract]   [Full Text] [Related]  

  • 13. Juxtafoveal telangiectasias.
    Querques G; Delle Noci N
    Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
    [No Abstract]   [Full Text] [Related]  

  • 14. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
    Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
    Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of idiopathic parafoveal telangiectasia associated with central serous chorioretinopathy.
    Thomas NR; Roy R; Saurabh K; Das K
    Indian J Ophthalmol; 2017 Jun; 65(6):516-517. PubMed ID: 28643718
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.
    Fallano KA; Ibrahim M; Nguyen QD; Do DV
    Can J Ophthalmol; 2010 Dec; 45(6):649-50. PubMed ID: 20648067
    [No Abstract]   [Full Text] [Related]  

  • 17. Volume-Rendering Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.
    Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Balaratnasingam C; Dansingani KK; Suzuki M
    Ophthalmology; 2015 Nov; 122(11):2261-9. PubMed ID: 26315043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of Coats disease.
    Sigler EJ; Randolph JC; Calzada JI; Wilson MW; Haik BG
    Surv Ophthalmol; 2014; 59(1):30-46. PubMed ID: 24138893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic challenges.
    Yang S; Borirakchanyavat S; Chan-Kai BT; Stout JT; Fu AD
    Retina; 2009 May; 29(5):708-14. PubMed ID: 19430282
    [No Abstract]   [Full Text] [Related]  

  • 20. Masquerade macular exudation in Mallatia Leventinese.
    Ewe SY; Jamieson R; Chang AA
    Can J Ophthalmol; 2016 Feb; 51(1):e27-9. PubMed ID: 26874169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.